MRI Interventions ClearPoint(R) Neuro Navigation System Recognized as Realtime Solution for Frameless Brain Biopsy in the Journal of Neurosurgery

Published on:

IRVINE, Calif., Nov. 2, 2015 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the publication of a Technical Note in the Journal of Neurosurgery regarding the use of the Company's ClearPoint Neuro Navigation System in frameless, MRI-guided brain biopsy. The Technical Note highlighted the ClearPoint System's safety advantages of real-time visualization, ability to make adjustments and confirmation of trajectory and targeting through a minimally invasive approach.

Traditional frame-based stereotactic biopsies rely on preoperative images which limit the ability to account for the shift of intracranial structures, which may reduce the target accuracy at the biopsy site resulting in a missed sample.

"The ClearPoint system has already been used with Electrode Placement, Drug Infusion and Laser Ablation," said Dr. J. Bradley Elder, Associate Professor of Neurological Surgery at The Ohio State University Wexner Medical Center. "Application of this technology to biopsy provides real time adaptability for needle trajectory, immediate imaging of complications and could eliminate misdiagnosis," said Dr. Elder.

The ClearPoint Neuro Navigation System is the only technology that enables minimally-invasive neurosurgery under continuous MRI guidance, offering surgeons real-time direction and a direct view of the inside of a patient's brain during a procedure. MRI provides superior visualization of the brain's tissue compared to other imaging technologies.

About MRI Interventions, Inc.
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The ClearPoint system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.

Related Content

What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Design by Adaptive Theme
Trimed Popup
Trimed Popup